Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Inclusion Criteria:

• Adults (≥ 18 years)

• English- and Spanish-fluent participants with thoracic and/or gastrointestinalcancers who are scheduled to initiate or continue outpatient chemotherapy at eitherMDACC (Texas Medical Center campus and any Houston-area location) or MDACC oncologyclinic at Lyndon B Johnson (LBJ) hospital

• Their adult (≥18 years) patient-identified or self-identified primary caregivers (MDACC only)

• Participants on combination chemotherapy and immunotherapy or combinationchemotherapy and biologic will also be eligible for inclusion.

• Participants may participate if they do not have a caregiver, or if their caregiverdeclines participation; however, caregivers of MDACC participants may participateonly if the participant consents.

Exclusion Criteria:

• Participants who are receiving investigational new drug treatments or concurrentlyenrolled in a phase 1 clinical trial will be excluded due to the associatedstructured reporting and regulatory requirements.

• Participants with a requirement for inpatient infusion (i.e. CAR-T cell therapy),living in institutional settings (i.e. prison, nursing homes), with a history ofdementia, physical disability or neurological deficits that prohibit ability toreport symptom burden will also be excluded.